Patents by Inventor Marc W. Weimer
Marc W. Weimer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12102736Abstract: Medical articles formed from a polyurethane-based resin including an ionically-charged modifier provide enhanced properties. The polyurethane-based resin is a reaction product of ingredients comprising: a diisocyanate; a diol chain extender; a polyglycol; and an ionically-charged modifier incorporated into a backbone, as a side chain, or both of the polyurethane-based resin. Embodiments include the ionically-charged modifier is a combination of anionic and cationic modifiers. Embodiments include the ionically-charged modifier is zwitterionic. Medical articles herein either have inherent antimicrobial and/or anti-fouling characteristics or can easily bond ionic active agents to provide desirable material properties, including antimicrobial, anti-fouling, and/or radiopacity.Type: GrantFiled: February 25, 2022Date of Patent: October 1, 2024Assignee: Becton, Dickinson and CompanyInventors: He Bai, Marc W. Weimer, James Freasier
-
Publication number: 20230159843Abstract: Medical articles formed from a polyurethane-based resin including a modifying oligomer provide enhanced properties. A modifying oligomer incorporated into a backbone, as a side chain, or both of the polyurethane-based resin formed by a diisocyanate, a polyglycol, and a diol chain extender has at least one, preferably two, alcohol moieties (C—OH) and a functional moiety. Exemplary modifying oligomers are: a diol-containing perfluoropolyether incorporated into the backbone, a monofunctional polysiloxane (e.g., monodialcohol-terminated polydimethylsiloxane) incorporated as the side chain, and combinations thereof. Medical articles herein are self-lubricating and/or anti-fouling.Type: ApplicationFiled: January 10, 2023Publication date: May 25, 2023Applicant: Becton , Dickinson and CompanyInventors: He Bai, Marc W. Weimer
-
Patent number: 11478573Abstract: Catheter tubing comprises: an elongate body comprising a base thermoplastic polyurethane; and a compounded thermoplastic polyurethane co-extruded with the base thermoplastic polyurethane to provide a section of catheter tubing discrete from the elongate body, the compounded thermoplastic polyurethane comprising a thermoplastic polyurethane and a radiopaque material, wherein the catheter tubing comprises a first elastic modulus under first conditions prior to entry into a patient; and wherein when exposed to second conditions comprising two or more in vivo stimuli for a duration of time the catheter tubing comprises a second elastic modulus that is not more than fifty percent of the first modulus.Type: GrantFiled: February 12, 2020Date of Patent: October 25, 2022Assignee: Becton, Dickinson and CompanyInventors: Lisa Lim, Theresa Hermel-Davidock, Marc W. Weimer, Jonathan Karl Burkholz
-
Publication number: 20220265906Abstract: Medical articles formed from a polyurethane-based resin including an ionically-charged modifier provide enhanced properties. The polyurethane-based resin is a reaction product of ingredients comprising: a diisocyanate; a diol chain extender; a polyglycol; and a cationic modifier incorporated into a backbone, as a side chain, or both of the polyurethane-based resin. Exemplary cationic modifier includes bis(2-hydroxyethyl)dimethylammonium chloride (BHDAC). Medical articles herein either have inherent antimicrobial and/or anti-fouling characteristics or can easily bond anionic active agents to provide desirable material properties, including antimicrobial and anti-fouling.Type: ApplicationFiled: February 25, 2022Publication date: August 25, 2022Applicant: Becton, Dickinson and CompanyInventors: He Bai, Marc W. Weimer, James Freasier
-
Publication number: 20220265904Abstract: Medical articles formed from a polyurethane-based resin including an ionically-charged modifier provide enhanced properties. The polyurethane-based resin is a reaction product of ingredients comprising: a diisocyanate; a diol chain extender; a polyglycol; and an ionically-charged modifier incorporated into a backbone, as a side chain, or both of the polyurethane-based resin. Embodiments include the ionically-charged modifier is a combination of anionic and cationic modifiers. Embodiments include the ionically-charged modifier is zwitterionic. Medical articles herein either have inherent antimicrobial and/or anti-fouling characteristics or can easily bond ionic active agents to provide desirable material properties, including antimicrobial, anti-fouling, and/or radiopacity.Type: ApplicationFiled: February 25, 2022Publication date: August 25, 2022Applicant: Becton, Dickinson and CompanyInventors: He Bai, Marc W. Weimer, James Freasier
-
Publication number: 20220265905Abstract: Medical articles formed from a polyurethane-based resin including an ionically-charged modifier provide enhanced properties. The polyurethane-based resin is a reaction product of ingredients comprising: a diisocyanate; a diol chain extender; a polyglycol; and an anionic modifier incorporated into a backbone, as a side chain, or both of the polyurethane-based resin. Exemplary anionic modifier includes 2,2-bis(hydroxymethyl)butyric acid (BHMBA) and/or bis-1,4-((2-hydroxypropoxy)-2-propoxy)-butane sulfonate sodium salt (SULFADIOL®-7Q). Medical articles herein either have inherent antimicrobial and/or anti-fouling characteristics or can easily bond cationic active agents to provide desirable material properties, including antimicrobial, anti-fouling, and/or radiopacity.Type: ApplicationFiled: February 25, 2022Publication date: August 25, 2022Applicant: Becton, Dickinson and CompanyInventors: He Bai, Hua Zhang, Marc W. Weimer, James Freasier
-
Publication number: 20200179572Abstract: Catheter tubing comprises: an elongate body comprising a base thermoplastic polyurethane; and a compounded thermoplastic polyurethane co-extruded with the base thermoplastic polyurethane to provide a section of catheter tubing discrete from the elongate body, the compounded thermoplastic polyurethane comprising a thermoplastic polyurethane and a radiopaque material, wherein the catheter tubing comprises a first elastic modulus under first conditions prior to entry into a patient; and wherein when exposed to second conditions comprising two or more in vivo stimuli for a duration of time the catheter tubing comprises a second elastic modulus that is not more than fifty percent of the first modulus.Type: ApplicationFiled: February 12, 2020Publication date: June 11, 2020Inventors: Lisa Lim, Theresa Hermel-Davidock, Marc W. Weimer, Jonathan Karl Burkholz
-
Publication number: 20200093969Abstract: Medical articles formed from a polyurethane-based resin including a modifying oligomer provide enhanced properties. A modifying oligomer incorporated into a backbone, as a side chain, or both of the polyurethane-based resin formed by a diisocyanate, a polyglycol, and a diol chain extender has at least one, preferably two, alcohol moieties (C—OH) and a functional moiety. Exemplary modifying oligomers are: a diol-containing perfluoropolyether incorporated into the backbone, a monofunctional polysiloxane (e.g., monodialcohol-terminated polydimethylsiloxane) incorporated as the side chain, and combinations thereof. Medical articles herein are self-lubricating and/or anti-fouling.Type: ApplicationFiled: September 20, 2019Publication date: March 26, 2020Inventors: He Bai, Marc W. Weimer
-
Publication number: 20200095515Abstract: Medical articles formed from a polyurethane-based resin including a modifying oligomer provide enhanced properties. A modifying oligomer incorporated into a backbone, as a side chain, or both of the polyurethane-based resin formed by a diisocyanate, a polyglycol, and a diol chain extender has at least one, preferably two, alcohol moieties (C—OH) and a functional moiety. Exemplary modifying oligomers are: a diol-containing perfluoropolyether incorporated into the backbone, a monofunctional polysiloxane (e.g., monodialcohol-terminated polydimethylsiloxane) incorporated as the side chain, and combinations thereof. Medical articles herein are self-lubricating and/or anti-fouling.Type: ApplicationFiled: September 20, 2019Publication date: March 26, 2020Inventors: He Bai, Marc W. Weimer
-
Patent number: 10596302Abstract: Catheter tubing comprises: an elongate body comprising a base thermoplastic polyurethane; and a compounded thermoplastic polyurethane co-extruded with the base thermoplastic polyurethane to provide a section of catheter tubing discrete from the elongate body, the compounded thermoplastic polyurethane comprising a thermoplastic polyurethane and a radiopaque material, wherein the catheter tubing comprises a first elastic modulus under first conditions prior to entry into a patient; and wherein when exposed to second conditions comprising two or more in vivo stimuli for a duration of time the catheter tubing comprises a second elastic modulus that is not more than fifty percent of the first modulus.Type: GrantFiled: April 17, 2017Date of Patent: March 24, 2020Assignee: Becton, Dickinson and CompanyInventors: Lisa Lim, Theresa Hermel-Davidock, Marc W. Weimer, Jonathan Karl Burkholz
-
Patent number: 10583269Abstract: Catheters, vascular access devices using such catheters, methods of using such catheters and uses of such catheters are disclosed. The catheter comprises polymeric tubing including a composition that can be magnetized by application of an externally applied magnetic field, thereby magnetizing the tubing. Detection of the magnetic field provides location information for the catheter in the vasculature.Type: GrantFiled: June 1, 2016Date of Patent: March 10, 2020Assignee: Becton, Dickinson and CompanyInventors: Jonathan Karl Burkholz, Ming Zhou, Siddarth Shevgoor, Marc W. Weimer
-
Publication number: 20180296731Abstract: Catheter tubing comprises: an elongate body comprising a base thermoplastic polyurethane; and a compounded thermoplastic polyurethane co-extruded with the base thermoplastic polyurethane to provide a section of catheter tubing discrete from the elongate body, the compounded thermoplastic polyurethane comprising a thermoplastic polyurethane and a radiopaque material, wherein the catheter tubing comprises a first elastic modulus under first conditions prior to entry into a patient; and wherein when exposed to second conditions comprising two or more in vivo stimuli for a duration of time the catheter tubing comprises a second elastic modulus that is not more than fifty percent of the first modulus.Type: ApplicationFiled: April 17, 2017Publication date: October 18, 2018Inventors: Lisa Lim, Theresa Hermel-Davidock, Marc W. Weimer, Jonathan Karl Burkholz
-
Publication number: 20170348509Abstract: Catheters, vascular access devices using such catheters, methods of using such catheters and uses of such catheters are disclosed. The catheter comprises polymeric tubing including a composition that can be magnetized by application of an externally applied magnetic field, thereby magnetizing the tubing. Detection of the magnetic field provides location information for the catheter in the vasculature.Type: ApplicationFiled: June 1, 2016Publication date: December 7, 2017Inventors: Jonathan Karl Burkholz, Ming Zhou, Siddarth Shevgoor, Marc W. Weimer
-
Patent number: 9110372Abstract: Novel, wet developable anti-reflective coating compositions and methods of using those compositions are provided. The compositions comprise a polymer and/or oligomer having acid functional groups and dissolved in a solvent system along with a crosslinker and a photoacid generator. The preferred acid functional group is a carboxylic acid, while the preferred crosslinker is a vinyl ether crosslinker. In use, the compositions are applied to a substrate and thermally crosslinked. Upon exposure to light, the cured compositions will decrosslink, rendering them soluble in typical photoresist developing solutions (e.g., alkaline developers).Type: GrantFiled: December 20, 2010Date of Patent: August 18, 2015Assignee: Brewer Science Inc.Inventors: Douglas J. Guerrero, Robert Christian Cox, Marc W. Weimer
-
Publication number: 20120156613Abstract: Novel, wet developable anti-reflective coating compositions and methods of using those compositions are provided. The compositions comprise a polymer and/or oligomer having acid functional groups and dissolved in a solvent system along with a crosslinker and a photoacid generator. The preferred acid functional group is a carboxylic acid, while the preferred crosslinker is a vinyl ether crosslinker. In use, the compositions are applied to a substrate and thermally crosslinked. Upon exposure to light, the cured compositions will decrosslink, rendering them soluble in typical photoresist developing solutions (e.g., alkaline developers).Type: ApplicationFiled: December 20, 2010Publication date: June 21, 2012Applicant: BREWER SCIENCE INC.Inventors: Douglas J. Guerrero, Robert Christian Cox, Marc W. Weimer
-
Patent number: 7976894Abstract: Novel materials with thermally reversible curing mechanisms are provided. These inventive compositions are useful in forming microelectronic structures, such as dual damascene structures. The compositions comprise a crosslinkable polymer dispersed or dissolved in a solvent system with a crosslinking agent. In use, the compositions are applied to a substrate and crosslinked. Additional layers may be applied on top of the cured layer followed by additional processing steps. Upon exposure to a temperature above the crosslinking temperature of the composition, the cured layer will undergo a decrosslinking reaction to render the layer soluble in common photoresist solvents, including solvents used to make the composition itself. Thus, after processing, the remaining material can be dissolved away without damaging the substrate. The inventive materials are especially suited for processes involving low-k dielectric substrates.Type: GrantFiled: November 13, 2008Date of Patent: July 12, 2011Assignee: Brewer Science Inc.Inventors: Daniel M. Sullivan, Marc W. Weimer
-
Patent number: 7833692Abstract: Novel, poison-blocking compositions and methods of using those compositions to form poison-blocking layers are provided. The compositions comprise a typical composition used in microlithographic processes, but with a poison-blocking additive included in that composition. The preferred additive is a compound comprising one or more blocked isocyanates. Upon heating to certain temperatures, the blocking group is released from the isocyanate, leaving behind a moiety that is highly reactive with the poisonous amines generated by typical dielectric layers.Type: GrantFiled: March 6, 2008Date of Patent: November 16, 2010Assignee: Brewer Science Inc.Inventor: Marc W. Weimer
-
Publication number: 20090317747Abstract: Novel, wet developable anti-reflective coating compositions and methods of using those compositions are provided. The compositions comprise a polymer and/or oligomer having acid functional groups and dissolved in a solvent system along with a crosslinker and a photoacid generator. The preferred acid functional group is a carboxylic acid, while the preferred crosslinker is a vinyl ether crosslinker. In use, the compositions are applied to a substrate and thermally crosslinked. Upon exposure to light, the cured compositions will decrosslink, rendering them soluble in typical photoresist developing solutions (e.g., alkaline developers).Type: ApplicationFiled: August 31, 2009Publication date: December 24, 2009Inventors: Douglas J. Guerrero, Robert Christian Cox, Marc W. Weimer
-
Patent number: 7601483Abstract: Novel, wet developable anti-reflective coating compositions and methods of using those compositions are provided. The compositions comprise a polymer and/or oligomer having acid functional groups and dissolved in a solvent system along with a crosslinker and a photoacid generator. The preferred acid functional group is a carboxylic acid, while the preferred crosslinker is a vinyl ether crosslinker. In use, the compositions are applied to a substrate and thermally crosslinked. Upon exposure to light, the cured compositions will decrosslink, rendering them soluble in typical photoresist developing solutions (e.g., alkaline developers).Type: GrantFiled: December 20, 2006Date of Patent: October 13, 2009Assignee: Brewer Science Inc.Inventors: Douglas J. Guerrero, Robert Christian Cox, Marc W. Weimer
-
Publication number: 20090011361Abstract: Novel, poison-blocking compositions and methods of using those compositions to form poison-blocking layers are provided. The compositions comprise a typical composition used in microlithographic processes, but with a poison-blocking additive included in that composition. The preferred additive is a compound comprising one or more blocked isocyanates. Upon heating to certain temperatures, the blocking group is released from the isocyanate, leaving behind a moiety that is highly reactive with the poisonous amines generated by typical dielectric layers.Type: ApplicationFiled: March 6, 2008Publication date: January 8, 2009Inventor: Marc W. Weimer